Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Halozyme Therapeutics ROA 2006-2020 | HALO

For a detailed definition, formula and example for ROA, check out our new background page here.
Current and historical return on assets (ROA) values for Halozyme Therapeutics (HALO) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
  
Halozyme Therapeutics ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2020-12-31 $0.13B $0.58B 24.31%
2020-09-30 $0.02B $0.52B 4.17%
2020-06-30 $-0.04B $0.53B -7.98%
2020-03-31 $-0.08B $0.49B -17.33%
2019-12-31 $-0.07B $0.57B -16.15%
2019-09-30 $-0.04B $0.37B -9.66%
2019-06-30 $-0.04B $0.42B -9.93%
2019-03-31 $-0.05B $0.43B -11.40%
2018-12-31 $-0.08B $0.44B -17.25%
2018-09-30 $0.05B $0.45B 9.51%
2018-06-30 $0.08B $0.48B 16.68%
2018-03-31 $0.07B $0.50B 16.07%
2017-12-31 $0.06B $0.52B 17.39%
2017-09-30 $-0.09B $0.36B -29.55%
2017-06-30 $-0.12B $0.35B -43.01%
2017-03-31 $-0.12B $0.23B -43.49%
2016-12-31 $-0.10B $0.26B -35.86%
2016-09-30 $-0.07B $0.28B -26.94%
2016-06-30 $-0.07B $0.30B -28.33%
2016-03-31 $-0.04B $0.31B -17.96%
2015-12-31 $-0.03B $0.18B -18.99%
2015-09-30 $-0.04B $0.16B -24.92%
2015-06-30 $-0.04B $0.17B -22.29%
2015-03-31 $-0.06B $0.16B -33.33%
2014-12-31 $-0.07B $0.17B -38.26%
2014-09-30 $-0.09B $0.17B -52.55%
2014-06-30 $-0.08B $0.18B -56.76%
2014-03-31 $-0.09B $0.20B -70.41%
2013-12-31 $-0.08B $0.10B -76.15%
2013-09-30 $-0.07B $0.11B -55.44%
2013-06-30 $-0.07B $0.11B -56.53%
2013-03-31 $-0.06B $0.12B -47.30%
2012-12-31 $-0.05B $0.14B -42.40%
2012-09-30 $-0.07B $0.11B -62.18%
2012-06-30 $-0.04B $0.12B -41.90%
2012-03-31 $-0.03B $0.14B -27.10%
2011-12-31 $-0.02B $0.07B -25.40%
2011-09-30 $-0.02B $0.08B -22.35%
2011-06-30 $-0.04B $0.09B -39.78%
2011-03-31 $-0.05B $0.08B -63.16%
2010-12-31 $-0.05B $0.09B -69.06%
2010-09-30 $-0.05B $0.10B -66.89%
2010-06-30 $-0.05B $0.05B -73.12%
2010-03-31 $-0.06B $0.07B -69.14%
2009-12-31 $-0.06B $0.08B -71.95%
2009-09-30 $-0.06B $0.09B -76.83%
2009-06-30 $-0.06B $0.10B -74.30%
2009-03-31 $-0.05B $0.07B -68.35%
2008-12-31 $-0.05B $0.08B -56.65%
2008-09-30 $-0.04B $0.08B -44.09%
2008-06-30 $-0.04B $0.09B -36.91%
2008-03-31 $-0.03B $0.10B -29.81%
2007-12-31 $-0.02B $0.10B -24.55%
2007-09-30 $-0.02B $0.11B -22.75%
2007-06-30 $-0.02B $0.10B -26.45%
2007-03-31 $-0.01B $0.07B -36.13%
2006-12-31 $-0.01B $0.05B -56.00%
2006-09-30 $-0.01B $0.02B -74.67%
2006-06-30 $-0.01B $0.02B -87.50%
2006-03-31 $-0.01B $0.02B -96.55%
2005-12-31 $-0.01B $0.02B -105.66%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $5.467B $0.268B
Halozyme Therapeutics, Inc. is a therapeutically driven, development stage biopharmaceutical company dedicated to developing and commercializing recombinant human enzymes for the infertility, ophthalmology, and oncology communities. The company's broad product development portfolio, including expected near- and long-term product offerings, is based on intellectual property covering the family of human enzymes known as hyaluronidases. The company's initial products are being developed to offer safer and purer alternatives toexisting slaughterhouse derived extracts that carry risks of pathogen contamination, immunogenicity, and toxicity. The commercialization of Halozyme's highly versatile enzyme technology within proven markets will enable the company to positively impact the quality of medicine.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.950B 9.21
Amgen (AMGN) United States $128.168B 13.37
CSL (CSLLY) Australia $89.421B 0.00
Gilead Sciences (GILD) United States $79.454B 8.92
Illumina (ILMN) United States $58.303B 88.80
Vertex Pharmaceuticals (VRTX) United States $54.017B 22.96
Moderna (MRNA) United States $52.890B 0.00
Regeneron Pharmaceuticals (REGN) United States $48.143B 15.73
Biogen (BIIB) United States $40.151B 8.03
Alexion Pharmaceuticals (ALXN) United States $32.639B 12.71
BeiGene (BGNE) Cayman Islands $26.456B 0.00
Seagen (SGEN) United States $26.350B 45.17
BioNTech SE (BNTX) Germany $22.911B 0.00
Exact Sciences (EXAS) United States $20.464B 0.00
Genmab (GMAB) Denmark $20.267B 28.37
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $19.827B 0.00
Horizon Therapeutics Public (HZNP) Ireland $19.311B 22.16
Genmab (GNMSF) Denmark $18.450B 4.37
Bio-Rad Laboratories (BIO.B) United States $17.927B 57.05
Incyte (INCY) United States $17.038B 0.00
Alnylam Pharmaceuticals (ALNY) United States $16.073B 0.00
BioMarin Pharmaceutical (BMRN) United States $13.883B 110.65
ARGENX SE-ADR (ARGX) Netherlands $13.790B 0.00
Bio-Techne Corp (TECH) United States $13.498B 77.31
Guardant Health (GH) United States $13.372B 0.00
Zai Lab (ZLAB) China $11.713B 0.00
Novavax (NVAX) United States $11.677B 0.00
QIAGEN (QGEN) Netherlands $10.836B 22.13
Repligen (RGEN) United States $10.035B 110.37
Mirati Therapeutics (MRTX) United States $9.165B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $8.711B 0.00
Ultragenyx Pharmaceutical (RARE) United States $7.942B 0.00
Fate Therapeutics (FATE) United States $7.797B 0.00
Acceleron Pharma (XLRN) United States $7.744B 0.00
Ascendis Pharma (ASND) Denmark $7.663B 0.00
ACADIA Pharmaceuticals (ACAD) United States $7.333B 0.00
Denali Therapeutics (DNLI) United States $7.102B 225.77
Exelixis (EXEL) United States $6.649B 60.89
Sarepta Therapeutics (SRPT) United States $6.525B 0.00
Adaptive Biotechnologies (ADPT) United States $6.081B 0.00
Twist Bioscience (TWST) United States $5.673B 0.00
Galapagos (GLPG) Belgium $5.552B 0.00
Blueprint Medicines (BPMC) United States $5.333B 17.56
NeoGenomics (NEO) United States $5.285B 645.57
Vir Biotechnology (VIR) United States $5.071B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $4.890B 15.38
Emergent Biosolutions (EBS) United States $4.843B 11.58
Biohaven Pharmaceutical Holding (BHVN) United States $4.821B 0.00
Certara (CERT) United States $4.669B 0.00
China Biologic Products (CBPO) China $4.647B 30.12
Arena Pharmaceuticals (ARNA) United States $4.315B 0.00
Reata Pharmaceuticals (RETA) United States $4.263B 0.00
Beam Therapeutics (BEAM) United States $4.260B 0.00
I-Mab (IMAB) China $3.997B 0.00
Insmed (INSM) United States $3.842B 0.00
Intellia Therapeutics (NTLA) United States $3.686B 0.00
Apellis Pharmaceuticals (APLS) United States $3.669B 0.00
Arvinas (ARVN) United States $3.474B 0.00
Berkeley Lights (BLI) United States $3.458B 0.00
SpringWorks Therapeutics (SWTX) United States $3.394B 0.00
MorphoSys AG (MOR) Germany $3.171B 114.76
Legend Biotech (LEGN) United States $3.109B 0.00
Viela Bio (VIE) United States $2.910B 0.00
Alkermes (ALKS) Ireland $2.900B 0.00
NantKwest (NK) United States $2.807B 0.00
Amicus Therapeutics (FOLD) United States $2.736B 0.00
Editas Medicine (EDIT) United States $2.719B 0.00
Intra-Cellular Therapies (ITCI) United States $2.692B 0.00
Global Blood Therapeutics (GBT) United States $2.507B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.476B 0.00
Sorrento Therapeutics (SRNE) United States $2.474B 0.00
Arcus Biosciences (RCUS) United States $2.367B 0.00
Ligand Pharmaceuticals (LGND) United States $2.354B 44.56
Morphic Holding (MORF) United States $2.242B 0.00
Amarin (AMRN) Ireland $2.224B 0.00
PHARMA MAR SA (PHMMF) Spain $2.211B 0.00
Myriad Genetics (MYGN) United States $2.138B 0.00
Dicerna Pharmaceuticals (DRNA) United States $2.065B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.987B 16.45
Genetron Holdings (GTH) China $1.916B 0.00
Inovio Pharmaceuticals (INO) United States $1.900B 0.00
Bluebird Bio (BLUE) United States $1.876B 0.00
NGM Biopharmaceuticals (NGM) United States $1.864B 0.00
Vericel (VCEL) United States $1.857B 808.20
Revance Therapeutics (RVNC) United States $1.835B 0.00
Pandion Therapeutics (PAND) United States $1.815B 0.00
Scholar Rock Holding (SRRK) United States $1.702B 0.00
Precigen (PGEN) United States $1.684B 0.00
REGENXBIO (RGNX) United States $1.666B 0.00
Seres Therapeutics (MCRB) United States $1.653B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.637B 0.00
Sangamo Therapeutics (SGMO) United States $1.609B 0.00
Travere Therapeutics (TVTX) United States $1.587B 0.00
Heska (HSKA) United States $1.582B 0.00
UniQure (QURE) Netherlands $1.483B 0.00
Zymeworks (ZYME) Canada $1.474B 0.00
Y-mAbs Therapeutics (YMAB) United States $1.446B 0.00
Five Prime Therapeutics (FPRX) United States $1.445B 0.00
Frequency Therapeutics (FREQ) United States $1.406B 0.00
Castle Biosciences (CSTL) United States $1.376B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.376B 0.00
Zealand Pharma (ZEAL) Denmark $1.346B 0.00
Cytokinetics (CYTK) United States $1.321B 0.00
Alector (ALEC) United States $1.293B 0.00
Codexis (CDXS) United States $1.289B 0.00
Nurix Therapeutics (NRIX) United States $1.264B 0.00
Mersana Therapeutics (MRSN) United States $1.249B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $1.197B 0.00
Northwest Biotherapeutics (NWBO) United States $1.150B 0.00
Zealand Pharma (ZLDPF) Denmark $1.141B 0.00
Pliant Therapeutics (PLRX) United States $1.140B 0.00
MiMedx (MDXG) United States $1.118B 0.00
Coherus BioSciences (CHRS) United States $1.110B 9.02
Mesoblast (MESO) Australia $1.079B 0.00
Protagonist Therapeutics (PTGX) United States $1.075B 0.00
Adverum Biotechnologies (ADVM) United States $1.072B 0.00
Bionano Genomics (BNGO) United States $1.057B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $1.046B 0.00
Repare Therapeutics (RPTX) Canada $1.008B 0.00
Celldex Therapeutics (CLDX) United States $0.997B 0.00
Avid Bioservices (CDMO) United States $0.967B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.960B 40.67
Dynavax Technologies (DVAX) United States $0.959B 0.00
Epizyme (EPZM) United States $0.936B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.925B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.923B 0.00
Cara Therapeutics (CARA) United States $0.902B 226.00
G1 THERAPEUTICS (GTHX) United States $0.852B 0.00
Prothena (PRTA) Ireland $0.847B 0.00
Pharming Group (PHGUF) Netherlands $0.838B 22.32
Pharming Group (PHAR) $0.838B 0.00
MannKind (MNKD) United States $0.835B 0.00
Cellectis S.A (CLLS) France $0.820B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.807B 0.00
Kadmon Holdings (KDMN) United States $0.798B 0.00
Sutro Biopharma (STRO) United States $0.783B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.777B 0.00
AnaptysBio (ANAB) United States $0.770B 0.00
Cel-Sci (CVM) United States $0.743B 0.00
VBI Vaccines (VBIV) United States $0.721B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.708B 0.00
Merus (MRUS) Netherlands $0.680B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.667B 0.00
ALBIREO PHARMA (ALBO) United States $0.647B 0.00
Starpharma Holdings (SPHRY) Australia $0.644B 0.00
Sinovac Biotech (SVA) China $0.640B 35.94
Intercept Pharmaceuticals (ICPT) United States $0.638B 0.00
Agenus (AGEN) United States $0.601B 0.00
ChromaDex (CDXC) United States $0.592B 0.00
Clovis Oncology (CLVS) United States $0.592B 0.00
Precision BioSciences (DTIL) United States $0.578B 0.00
Compugen (CGEN) Israel $0.558B 0.00
DBV Technologies S.A (DBVT) France $0.551B 0.00
Geron (GERN) United States $0.550B 0.00
Anika Therapeutics (ANIK) United States $0.542B 181.57
Curis (CRIS) United States $0.537B 0.00
MeiraGTx Holdings (MGTX) United States $0.534B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.526B 0.00
AC Immune SA (ACIU) Switzerland $0.526B 0.00
Gritstone Oncology (GRTS) United States $0.513B 0.00
Amryt Pharma (AMYT) United Kingdom $0.499B 0.00
Neoleukin Therapeutics (NLTX) United States $0.479B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.477B 0.00
AMMO (POWW) United States $0.458B 0.00
WAVE Life Sciences (WVE) Singapore $0.456B 0.00
Affimed (AFMD) Germany $0.453B 0.00
Syros Pharmaceuticals (SYRS) United States $0.447B 0.00
Spero Therapeutics (SPRO) United States $0.438B 0.00
Kala Pharmaceuticals (KALA) United States $0.436B 0.00
Puma Biotechnology (PBYI) United States $0.431B 0.00
AquaBounty Technologies (AQB) United States $0.429B 0.00
Athenex (ATNX) United States $0.419B 0.00
Selecta Biosciences (SELB) United States $0.412B 0.00
Fulcrum Therapeutics (FULC) United States $0.408B 0.00
BioDelivery Sciences (BDSI) United States $0.406B 19.14
UROGEN PHARMA (URGN) United States $0.396B 0.00
Opthea (OPT) Australia $0.395B 0.00
XOMA (XOMA) United States $0.390B 0.00
Kaleido Biosciences (KLDO) $0.389B 0.00
Fortress Biotech (FBIO) United States $0.387B 0.00
Verastem (VSTM) United States $0.377B 0.00
Cue Biopharma (CUE) United States $0.371B 0.00
Athersys (ATHX) United States $0.364B 0.00
CytomX Therapeutics (CTMX) United States $0.351B 0.00
ANI Pharmaceuticals (ANIP) United States $0.351B 8.93
Aeglea BioTherapeutics (AGLE) United States $0.343B 0.00
Forte Biosciences (FBRX) United States $0.340B 0.00
Cardiff Oncology (CRDF) United States $0.340B 0.00
Innate Pharma S.A (IPHA) France $0.340B 0.00
Trevena (TRVN) United States $0.327B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.324B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.322B 0.00
Oncobiologics (OTLK) United States $0.314B 0.00
NextCure (NXTC) United States $0.314B 0.00
IBio (IBIO) United States $0.309B 0.00
Bellus Health (BLU) Canada $0.309B 0.00
Theratechnologies (THTX) Canada $0.294B 0.00
PDL BioPharma (PDLI) United States $0.282B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.279B 0.00
Kamada (KMDA) Israel $0.268B 15.44
Arbutus Biopharma (ABUS) United States $0.267B 0.00
Evofem Biosciences (EVFM) United States $0.266B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.264B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.262B 0.00
HOOKIPA Pharma (HOOK) United States $0.252B 0.00
Cerecor (CERC) United States $0.242B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.235B 0.00
TELA Bio (TELA) United States $0.229B 0.00
CorMedix Inc (CRMD) United States $0.228B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.225B 0.00
OSMOTICA PHARM (OSMT) United States $0.218B 0.00
Applied Genetic Technologies (AGTC) United States $0.216B 0.00
ADMA Biologics Inc (ADMA) United States $0.211B 0.00
Voyager Therapeutics (VYGR) United States $0.210B 5.87
INmune Bio (INMB) United States $0.207B 0.00
Abeona Therapeutics (ABEO) United States $0.205B 0.00
Aptinyx (APTX) United States $0.202B 0.00
Chiasma (CHMA) United States $0.199B 0.00
POXEL SA FRANCE (PXXLF) France $0.197B 0.00
Checkpoint Therapeutics (CKPT) United States $0.196B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.192B 0.00
GENFIT S.A (GNFT) France $0.189B 0.00
Strongbridge Biopharma (SBBP) United States $0.187B 0.00
Eton Pharmaceuticals (ETON) United States $0.187B 0.00
VolitionRX (VNRX) United States $0.182B 0.00
Exicure (XCUR) United States $0.181B 0.00
Idera Pharmaceuticals (IDRA) United States $0.179B 0.00
Nicox SA (NICXF) France $0.177B 0.00
Kindred Biosciences (KIN) United States $0.173B 0.00
Orgenesis (ORGS) United States $0.170B 352.00
Pluristem Therapeutics (PSTI) Israel $0.169B 0.00
VTv Therapeutics (VTVT) United States $0.167B 0.00
Antibe Therapeutics (ATBPF) Canada $0.166B 0.00
DiaMedica Therapeutics (DMAC) United States $0.162B 0.00
Palatin Technologies (PTN) United States $0.161B 0.00
Clearside Biomedical (CLSD) United States $0.157B 0.00
Protalix BioTherapeutics (PLX) Israel $0.151B 0.00
X4 Pharmaceuticals (XFOR) United States $0.150B 0.00
Cogent Biosciences (COGT) United States $0.145B 0.00
Aptevo Therapeutics (APVO) United States $0.144B 0.00
Seelos Therapeutics (SEEL) United States $0.142B 0.00
Biofrontera AG (BFRA) Germany $0.141B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.140B 0.00
Dyadic (DYAI) United States $0.136B 0.00
Enzo Biochem (ENZ) United States $0.132B 0.00
Aytu Bioscience (AYTU) United States $0.131B 0.00
Catalyst Biosciences (CBIO) United States $0.130B 0.00
Cyclerion Therapeutics (CYCN) United States $0.128B 0.00
TRACON Pharmaceuticals (TCON) United States $0.126B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.126B 0.00
Evogene (EVGN) Israel $0.122B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.120B 0.00
Liminal BioSciences (LMNL) Canada $0.118B 0.00
Prima BioMed (IMMP) Australia $0.118B 0.00
CytRx (CYTR) United States $0.116B 0.00
Liquidia Technologies (LQDA) United States $0.115B 0.00
Cidara Therapeutics (CDTX) United States $0.112B 0.00
Beyond Air (XAIR) United States $0.112B 0.00
Lumos Pharma (LUMO) United States $0.112B 0.00
Ecology Coatings (ABVC) United States $0.110B 0.00
Synlogic (SYBX) United States $0.108B 0.00
PHASEBIO PHARMA (PHAS) United States $0.107B 0.00
ARAVIVE, INC (ARAV) United States $0.105B 0.00
Celyad SA (CYAD) Belgium $0.103B 0.00
Cocrystal Pharma (COCP) United States $0.095B 0.00
Adocia (ADOCY) France $0.092B 0.00
Novogen (KZIA) Australia $0.089B 0.00
Vascular Biogenics (VBLT) Israel $0.086B 0.00
AIkido Pharma (AIKI) United States $0.083B 0.00
Stealth BioTherapeutics (MITO) United States $0.083B 37.25
Organovo Holdings (ONVO) United States $0.081B 0.00
Advaxis (ADXS) United States $0.079B 0.00
Cleveland BioLabs (CBLI) United States $0.079B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.073B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.070B 0.00
Emmaus Life Sciences (EMMA) United States $0.070B 0.00
AEterna Zentaris (AEZS) United States $0.070B 0.00
Celsion (CLSN) United States $0.069B 0.00
Windtree Therapeutics (WINT) United States $0.068B 0.00
Vaccinex (VCNX) United States $0.066B 0.00
AnPac Bio-Medical Science (ANPC) China $0.066B 0.00
Edesa Biotech (EDSA) Canada $0.066B 0.00
Purple Biotech (PPBT) Israel $0.064B 0.00
ZIVO Bioscience (ZIVO) United States $0.063B 0.00
Genetic Technologies (GENE) Australia $0.062B 0.00
ARIDIS PHARMACT (ARDS) United States $0.057B 0.00
Acorda Therapeutics (ACOR) United States $0.054B 0.96
Viracta Therapeutics (VIRX) United States $0.054B 0.00
Soligenix (SNGX) United States $0.054B 0.00
Happiness Biotech Group (HAPP) China $0.048B 0.00
Pulmatrix (PULM) United States $0.047B 0.00
ATyr Pharma (LIFE) United States $0.045B 0.00
Enveric Biosciences (ENVB) United States $0.045B 0.00
Yumanity Therapeutics (YMTX) United States $0.044B 0.00
BioCardia (BCDA) United States $0.043B 0.00
Alimera Sciences (ALIM) United States $0.039B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.036B 0.00
IMMURON (IMRN) Australia $0.033B 0.00
Prana Biotechnology (ATHE) Australia $0.032B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.030B 0.00
Lexaria Bioscience (LEXX) Canada $0.028B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.026B 0.00
Titan Pharmaceuticals (TTNP) United States $0.021B 0.00
Timber Pharmaceuticals (TMBR) United States $0.020B 0.00
Seneca Biopharma (SNCA) United States $0.019B 0.00
ThermoGenesis Holdings (THMO) United States $0.018B 0.00
GeoVax Labs (GOVX) United States $0.018B 0.00
Invo BioScience (INVO) United States $0.016B 0.00
Cyclo Therapeutics (CYTH) United States $0.013B 0.00
Benitec Biopharma (BNTC) United States $0.012B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
Viridian Therapeutics (VRDN) United States $0.000B 0.00